These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19151603)

  • 21. Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes.
    Villagra D; Goethe J; Schwartz HI; Szarek B; Kocherla M; Gorowski K; Windemuth A; Ruaño G
    Biomark Med; 2011 Aug; 5(4):427-38. PubMed ID: 21861665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
    Jose R; Chandrasekaran A; Sam SS; Gerard N; Chanolean S; Abraham BK; Satyanarayanamoorthy K; Peter A; Rajagopal K
    Fundam Clin Pharmacol; 2005 Feb; 19(1):101-5. PubMed ID: 15660966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.
    Naujokaitis D; Asmoniene V; Kadusevicius E
    Medicine (Baltimore); 2021 Mar; 100(11):e24545. PubMed ID: 33725937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating the Correlation between Genotypes and Hepatic Protein Expression of
    Pedersen KW; Andersen JD; Hansen J; Børsting C; Banner J; Hasselstrøm JB; Jornil JR
    Drug Metab Dispos; 2024 Aug; 52(9):975-980. PubMed ID: 38906700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland China--a basis for personalized therapy.
    Wu Z; Zhang X; Shen L; Xiong Y; Wu X; Huo R; Wei Z; Cai L; Qi G; Xu Q; Cui D; Cui D; Zhao G; He L; Qin S
    PLoS One; 2013; 8(10):e71934. PubMed ID: 24098323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
    Zuo J; Xia D; Jia L; Guo T
    Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China.
    Yang ZF; Cui HW; Hasi T; Jia SQ; Gong ML; Su XL
    Genet Mol Res; 2010 Sep; 9(3):1844-51. PubMed ID: 20845310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CYP2D6-, CYP2C9- and CYP2C19-based dose adjustments: when do they make sense?].
    Seeringer A; Kirchheiner J
    Internist (Berl); 2008 Jul; 49(7):877-83. PubMed ID: 18551264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population.
    Caccamo D; Cesareo E; Mariani S; Raskovic D; Ientile R; Currò M; Korkina L; De Luca C
    Oxid Med Cell Longev; 2013; 2013():831969. PubMed ID: 23936614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population.
    Céspedes-Garro C; Rodrigues-Soares F; Jiménez-Arce G; Naranjo MG; Tarazona-Santos E; Fariñas H; Barrantes R; Llerena A;
    Rev Biol Trop; 2016 Sep; 64(3):1067-76. PubMed ID: 29461783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major CYP450 Polymorphism among Saudi Patients.
    Almeman AA
    Drug Metab Lett; 2021; 14(1):17-24. PubMed ID: 32703145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients.
    Serretti A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Sens-Espel R; Bollen J; Zohar J; Berlo J; Lienard P; De Ronchi D; Mendlewicz J; Souery D
    Int Clin Psychopharmacol; 2009 Sep; 24(5):250-6. PubMed ID: 19593158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese.
    He L; Chen S; Li J; Xie X; Huang L; Kuang Y; Xu K; Huang W; Zhao Y; Yang G; Guo C
    Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1659-1663. PubMed ID: 32469422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP2D6 and CYP2C19 genotypes and amitriptyline metabolite ratios in a series of medicolegal autopsies.
    Koski A; Sistonen J; Ojanperä I; Gergov M; Vuori E; Sajantila A
    Forensic Sci Int; 2006 May; 158(2-3):177-83. PubMed ID: 16024198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia.
    Jakovski K; Nestorovska AK; Labacevski N; Dimovski AJ
    Pharmazie; 2013 Nov; 68(11):893-8. PubMed ID: 24380239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates.
    Pimenoff VN; Laval G; Comas D; Palo JU; Gut I; Cann H; Excoffier L; Sajantila A
    Pharmacogenet Genomics; 2012 Dec; 22(12):846-57. PubMed ID: 23089684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).
    Pachkoria K; Lucena MI; Ruiz-Cabello F; Crespo E; Cabello MR; Andrade RJ;
    Br J Pharmacol; 2007 Mar; 150(6):808-15. PubMed ID: 17279092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.
    Fohner A; Muzquiz LI; Austin MA; Gaedigk A; Gordon A; Thornton T; Rieder MJ; Pershouse MA; Putnam EA; Howlett K; Beatty P; Thummel KE; Woodahl EL
    Pharmacogenet Genomics; 2013 Aug; 23(8):403-14. PubMed ID: 23778323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic.
    Müller DJ; Kekin I; Kao AC; Brandl EJ
    Int Rev Psychiatry; 2013 Oct; 25(5):554-71. PubMed ID: 24151801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.